These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34797583)

  • 1. The diagnostic accuracy of the faecal immunohistochemical test in identifying significant bowel disease in a symptomatic population.
    MacDonald S; MacDonald L; Godwin J; Macdonald A; Thornton M
    Colorectal Dis; 2022 Mar; 24(3):257-263. PubMed ID: 34797583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appraisal of the faecal haemoglobin, age and sex test (FAST) score in assessment of patients with lower bowel symptoms: an observational study.
    Digby J; Strachan JA; Mowat C; Steele RJC; Fraser CG
    BMC Gastroenterol; 2019 Dec; 19(1):213. PubMed ID: 31829141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal diagnostic accuracy of quantitative faecal immunochemical test positivity thresholds for colorectal cancer detection in primary health care: A community-based cohort study.
    Pin-Vieito N; García Nimo L; Bujanda L; Román Alonso B; Gutierrez-Stampa MÁ; Aguilar-Gama V; Portillo I; Cubiella J
    United European Gastroenterol J; 2021 Mar; 9(2):256-267. PubMed ID: 32778002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining the quantitative faecal immunochemical test and full blood count reliably rules out colorectal cancer in a symptomatic patient referral pathway.
    Johnstone MS; Burton P; Kourounis G; Winter J; Crighton E; Mansouri D; Witherspoon P; Smith K; McSorley ST
    Int J Colorectal Dis; 2022 Feb; 37(2):457-466. PubMed ID: 34932152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Service evaluation of faecal immunochemical testing and anaemia for risk stratification in the 2-week-wait pathway for colorectal cancer.
    Chapman C; Bunce J; Oliver S; Ng O; Tangri A; Rogers R; Logan RF; Humes DJ; Banerjea A
    BJS Open; 2019 Jun; 3(3):395-402. PubMed ID: 31183456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yield of colorectal cancer at colonoscopy according to faecal haemoglobin concentration in symptomatic patients referred from primary care.
    McSorley ST; Digby J; Clyde D; Cruickshank N; Burton P; Barker L; Strachan JA; Fraser CG; Smith K; Mowat C; Winter J; Steele RJC
    Colorectal Dis; 2021 Jul; 23(7):1615-1621. PubMed ID: 33064898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the faecal haemoglobin concentrations and diagnostic accuracy in patients suspected with colorectal cancer and serious bowel disease as reported on four different faecal immunochemical test systems.
    Benton SC; Piggott C; Zahoor Z; O'Driscoll S; Fraser CG; D'Souza N; Chen M; Georgiou Delisle T; Abulafi M
    Clin Chem Lab Med; 2022 Jul; 60(8):1278-1286. PubMed ID: 35637625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early clinical outcomes of a rapid colorectal cancer diagnosis pathway using faecal immunochemical testing in Nottingham.
    Chapman C; Thomas C; Morling J; Tangri A; Oliver S; Simpson JA; Humes DJ; Banerjea A
    Colorectal Dis; 2020 Jun; 22(6):679-688. PubMed ID: 31876975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of faecal haemoglobin with a faecal immunochemical test can assist in defining which patients attending primary care with rectal bleeding require urgent referral.
    Digby J; Strachan JA; McCann R; Steele RJ; Fraser CG; Mowat C
    Ann Clin Biochem; 2020 Jul; 57(4):325-327. PubMed ID: 32482080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Finding the needle in the haystack: the diagnostic accuracy of the faecal immunochemical test for colorectal cancer in younger symptomatic patients.
    D'Souza N; Monahan K; Benton SC; Wilde L; Abulafi M;
    Colorectal Dis; 2021 Oct; 23(10):2539-2549. PubMed ID: 34240526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction of an integrated primary care faecal immunochemical test referral pathway for patients with suspected colorectal cancer symptoms.
    Georgiou Delisle T; D'Souza N; Tan J; Najdawi A; Chen M; Ward H; Abulafi M
    Colorectal Dis; 2022 Dec; 24(12):1526-1534. PubMed ID: 35934985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An observational study of replicate faecal immunochemical tests in the urgently referred symptomatic cohort.
    Farkas NG; O'Brien J; Whyte M; Jourdan I; Rockall T; Benton SC
    Ann Clin Biochem; 2023 Sep; 60(5):313-319. PubMed ID: 36864586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using the faecal immunochemical test in patients with rectal bleeding: evidence from the NICE FIT study.
    Hicks G; D'Souza N; Georgiou Delisle T; Chen M; Benton SC; Abulafi M;
    Colorectal Dis; 2021 Jul; 23(7):1630-1638. PubMed ID: 33605522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.
    Digby J; Cleary S; Gray L; Datt P; Goudie DR; Steele RJC; Strachan JA; Humphries A; Fraser CG; Mowat C
    United European Gastroenterol J; 2020 Jun; 8(5):559-566. PubMed ID: 32213041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding colorectal cancer risk for symptomatic patients in primary care: A cohort study utilising faecal immunochemical tests and blood results in England.
    Crooks CJ; Banerjea A; Jones J; Chapman C; Oliver S; West J; Humes DJ
    Aliment Pharmacol Ther; 2023 Aug; 58(4):443-452. PubMed ID: 37421214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Low' faecal immunochemical test (FIT) colorectal cancer: a 4-year comparison of the Nottingham '4F' protocol with FIT10 in symptomatic patients.
    Bailey JA; Morton AJ; Jones J; Chapman CJ; Oliver S; Morling JR; Patel H; Humes DJ; Banerjea A
    Colorectal Dis; 2024 Feb; 26(2):309-316. PubMed ID: 38173125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do risk scores improve use of faecal immunochemical testing for haemoglobin in symptomatic patients in primary care?
    Digby J; Fraser CG; Clark G; Mowat C; Strachan JA; Steele RJC
    Colorectal Dis; 2024 Apr; 26(4):675-683. PubMed ID: 38424669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test.
    Pin-Vieito N; Iglesias MJ; Remedios D; Rodríguez-Alonso L; Rodriguez-Moranta F; Álvarez-Sánchez V; Fernández-Bañares F; Boadas J; Martínez-Bauer E; Campo R; Bujanda L; Ferrandez Á; Piñol V; Rodríguez-Alcalde D; Guardiola J; Cubiella J; On Behalf Of The Colonpredict Study Investigators
    World J Gastroenterol; 2020 Jan; 26(1):70-85. PubMed ID: 31933515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-risk symptoms and quantitative faecal immunochemical test accuracy: Systematic review and meta-analysis.
    Pin Vieito N; Zarraquiños S; Cubiella J
    World J Gastroenterol; 2019 May; 25(19):2383-2401. PubMed ID: 31148909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of a quantitative faecal immunochemical test vs. symptoms suspected for colorectal cancer in patients referred for colonoscopy.
    Tsapournas G; Hellström PM; Cao Y; Olsson LI
    Scand J Gastroenterol; 2020 Feb; 55(2):184-192. PubMed ID: 31906738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.